PHH2 on Frankfurt Stock Exchange

Paul Hartmann AG

Logo: PAUL HARTMANN AG, Public domain, via Wikimedia Commons4

Public company

The Hartmann Group, headquartered in Heidenheim, Baden-Württemberg, Germany, is a manufacturer of medical and care products, as well as a provider of associated services. The company primarily operates in three core segments: Wound Care; Incontinence Management; and Infection Management (encompassing business areas Risk Prevention and Disinfection). In 2025, the company achieved a revenue of €2.45 billion and employed 10,066 people.2 It was founded in 1818.1 Its shares trade on Frankfurt Stock Exchange under the symbol PHH2.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1818Founded1

Compare with another stock.

  • TickerPHH2 on Frankfurt Stock Exchange1
  • Industryindustry, manufacture of medical and dental instruments and supplies1
  • HeadquartersHeidenheim an der Brenz1
  • Websitewww.hartmann.info
  • Legal formAktiengesellschaft1
  • LEI5493008OWN3GUZK1EW253
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressPaul-Hartmann-Straße 12, 89522 Heidenheim an der Brenz, Germany3
  • Registered withLocal Court Ulm, HRB 6610903
2017-03-29 Truck Spotting @ The Bp Garage on the A17 A59 Direction Moerdijk-Holland - Gebr. Pothuizen Paul Hartmann
Photo: Rab,Driver of P300NJB @Grampian Continental.., CC BY 2.0, via Wikimedia Commons6

The Hartmann Group, headquartered in Heidenheim, Baden-Württemberg, Germany, is a manufacturer of medical and care products, as well as a provider of associated services. The company primarily operates in three core segments: Wound Care; Incontinence Management; and Infection Management (encompassing business areas Risk Prevention and Disinfection).2

Corporate structure

Paul Hartmann AG sits at the top of its group. 9 entities, 6 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Paul Hartmann AG Heidenheim an der Brenz, Germany
    • IVF Hartmann Subsidiary · 66.3% · Neuhausen am Rheinfall
    • Kneipp GmbH Subsidiary · Würzburg, Germany
    • Hartmann - Rico Subsidiary · 100% · Czechia
    • KOB MEDICAL TEXTILES PRIVATE LIMITED Subsidiary · Tiruppur, India
    • N.V. PAUL HARTMANN S.A. Subsidiary · Tubize, Belgium
    • NOGE Gesellschaft für Medizinprodukte und -dienstleistungen mbH Subsidiary · Heidenheim an der Brenz, Germany
    • Paul Hartmann Finance B.V. Subsidiary · Nijmegen, Netherlands
    • PAUL HARTMANN TIBBİ VE HİJYENİK ÜRÜNLER İTHALAT İHRACAT LİMİTED ŞİRKETİ Subsidiary · İstanbul, Turkey

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

What it owns

What Paul Hartmann AG reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Stakes and holdings (Wikidata)

Things Wikidata records the company as owning, with the share when stated.1

The story

Foundation and beginnings

The origins of Hartmann date back to 1818 when Ludwig von Hartmann took over a mechanical spinning mill in Heidenheim, which soon became one of the largest cotton mills in Germany.

In 1843, Ludwig von Hartmann transferred the business to his three sons.

The Tübingen surgeon Victor von Bruns developed an absorbent dressing cotton made from cotton through degreasing and bleaching, known as Bruns's wool, in 1865.

In 1873, Paul Hartmann began the production of degreased dressing cotton in Heidenheim. The dressings, known as Lister's Carbol-Gauze, were impregnated with antiseptics using a method developed by Joseph Lister and demonstrated germicidal properties. Lister's contributions resulted in a decrease in post-operative infections, enhancing the safety of surgical procedures for patients. This earned Lister the title of "father of modern surgery."

Expansion and acquisitions

In 1912, the company was transformed into a stock company under general director Walther Hartmann, the grandson of the founder Ludwig von Hartmann.

In 2000, the Hartmann Group acquired KOB GmbH (Karl Otto Braun). In 2005, Hartmann established the subsidiary CMC Consumer Medical Care GmbH to produce cotton/cosmetics, medical products, baby care, and home care products. The following years saw further expansion; in April 2008, Kneipp GmbH became a wholly owned subsidiary, and in October of the same year, Hartmann acquired Bode Chemie GmbH, a Hamburg-based provider of disinfection, hygiene, and skin protection products.

Recent developments

In January 2019, Britta Fünfstück took over as the new CEO of the company. Shortly after her appointment, Fünfstück presented a transformation plan that included investments in new products and digital business models, as well as a stronger focus of sales on the end customer.

In August 2019, Safran Coating, a company producing silicone coatings, was acquired, which has since been operating under the name Advanced Silicone Coating.

Read the full text

In 2021, Hartmann acquired pflege.de, an online platform which offers guidance and services for home care as well as care aid supply.

In July 2023, the company announced its plans to make further investments in Germany, including a double-digit million-euro investment for the production facility in Herbrechtingen, where adult incontinence products are manufactured.

From Wikipedia’s article on Hartmann Group, shared under CC BY-SA 4.0.5

Products and brands

The Hartmann Group produces medical and care products in the three main areas of wound care, incontinence management, and infection management.

In the wound care segment, Hartmann produces products for wound treatment and dressings. The company provides various traditional and modern wound dressings, including silicone-coated options, superabsorbent dressings, postoperative dressings, and postoperative dressings.

The incontinence management segment focuses on absorbent products for various levels of incontinence. The company also offers hygiene and skin care products for patients with incontinence. The company has also published the Europe-wide study "Breaking the Silence", evaluating how adults communicate about and deal with incontinence.

The infection management segment includes two main areas: risk prevention and disinfection. For risk prevention, Hartmann offers sterile component sets, examination gloves and surgical products that include single-use instruments, clothing, and drapes. In the disinfection division, the company develops and manufactures products for hand hygiene as well as hand and surface disinfection.

Read the full text

The segment of complementary divisions of the group includes the corporate subsidiaries Kneipp, CMC, and KOB. Kneipp manufactures body care products, dietary supplements, and herbal medicines. CMC primarily distributes private label products in the areas of cosmetics, cotton, medical supplies, baby care, and home care. KOB produces medical textiles such as compression, fixation, support, or relief bandages.

From Wikipedia’s article on Hartmann Group, shared under CC BY-SA 4.0.5

Subsidiaries and ownership

Owners

  • Eduard Schleicher 75%

Subsidiaries

Also owns

From Wikidata.1

Employees over time

Paul Hartmann AG employees by year110.1K in 2025−1% since 2014
05.0K10.0K15.0K2014: 10.2K10.2K20142015: 10.3K10.3K2015+1%2016: 10.4K10.4K2016+0%2017: 10.8K10.8K2017+4%2018: 11.0K11.0K2018+2%2019: 11.1K11.1K2019+1%2020: 10.6K10.6K2020−4%2021: 10.6K10.6K2021+0%2022: 10.3K10.3K2022−3%2025: 10.1K10.1K2025−2%
  • 202510,0661
  • 202210,2901
  • 202110,6281
  • 202010,6251
  • 201911,0961
  • 201811,0271
  • 201710,7641
  • 201610,3721

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

Paul Hartmann AG revenue by year12.4B EUR in 2025+29% since 2014
01.0B EUR2.0B EUR3.0B EUR2014: 1.9B EUR1.9B EUR20142015: 1.9B EUR1.9B EUR2015+4%2016: 2.0B EUR2.0B EUR2016+2%2017: 2.1B EUR2.1B EUR2017+4%2018: 2.1B EUR2.1B EUR2018+3%2019: 2.2B EUR2.2B EUR2019+3%2020: 2.4B EUR2.4B EUR2020+11%2021: 2.3B EUR2.3B EUR2021−5%2022: 2.3B EUR2.3B EUR2022+0%2025: 2.4B EUR2.4B EUR2025+4%
  • 20252.4B EUR1
  • 20222.3B EUR1
  • 20212.3B EUR1
  • 20202.4B EUR1
  • 20192.2B EUR1
  • 20182.1B EUR1

Net income

Paul Hartmann AG net income by year165.8M EUR in 2025−11% since 2014
050.0M EUR100.0M EUR150.0M EUR2014: 73.5M EUR73.5M EUR20142015: 78.9M EUR78.9M EUR2015+7%2016: 84.9M EUR84.9M EUR2016+8%2017: 88.2M EUR88.2M EUR2017+4%2018: 79.0M EUR79.0M EUR2018−10%2019: 58.3M EUR58.3M EUR2019−26%2020: 106.5M EUR106.5M EUR2020+83%2021: 94.7M EUR94.7M EUR2021−11%2022: 36.1M EUR36.1M EUR2022−62%2025: 65.8M EUR65.8M EUR2025+82%
  • 202565.8M EUR1
  • 202236.1M EUR1
  • 202194.7M EUR1
  • 2020106.5M EUR1
  • 201958.3M EUR1
  • 201879.0M EUR1

Timeline

  1. 1818Founded Founded1